Understanding the connection between stress and heart palpitations can be a crucial first step in managing these sometimes frightening episodes
In SURMOUNT-1, which enrolled adults with obesity or overweight without diabetes, participants receiving tirzepatide 5 mg, 10 mg, or 15 mg weekly achieved mean weight reductions of 15.0%, 19.5%, and 20.9% respectively at 72 weeks, compared to 3.1% with placebo
Ferraz-de-Souza, B., Lin, L
Manging interactions Tirzepatide may interact with other medications, which can affect their effectiveness or increase the risk of side effects
Semaglutide injections represent a significant advance in weight management, with clinical trials showing an average weight reduction of 10-15% over 68 weeks